N,N'-Dicyclohexyl-4-morpholinecarboxamidine structure
|
Common Name | N,N'-Dicyclohexyl-4-morpholinecarboxamidine | ||
|---|---|---|---|---|
| CAS Number | 4975-73-9 | Molecular Weight | 293.448 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 423.2±55.0 °C at 760 mmHg | |
| Molecular Formula | C17H31N3O | Melting Point | 105-107 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 209.7±31.5 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
| Name | N,N'-Dicyclohexyl-4-morpholinecarboxamidine |
|---|---|
| Synonym | More Synonyms |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 423.2±55.0 °C at 760 mmHg |
| Melting Point | 105-107 °C(lit.) |
| Molecular Formula | C17H31N3O |
| Molecular Weight | 293.448 |
| Flash Point | 209.7±31.5 °C |
| Exact Mass | 293.246704 |
| PSA | 36.86000 |
| LogP | 2.99 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.600 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Phrases | 36/37/38 |
| Safety Phrases | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | LQ4566500 |
| HS Code | 2934999090 |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir.
Antimicrob. Agents Chemother. 46(4) , 991-5, (2002) The nucleotide phosphonates cidofovir (CDV) and cyclic cidofovir (cCDV) are potent antiviral compounds when administered parenterally but are not well absorbed orally. These compounds have been report... |
|
|
Synthesis and diuretic activity of alkyl- and arylguanidine analogs of N,N'-dicyclohexyl-4-morpholinecarboxamidine in rats and dogs.
J. Med. Chem. 37(22) , 3693-700, (1994) Random screening identified N,N'-dicyclohexyl-4-morpholinecarboxamidine (U-18177, 1) as an orally effective nonkaliuretic diuretic in rats. The diuretic profile of 1 and its 1-adamantyl analog (U-3788... |
|
|
An ATP-sensitive potassium channel blocker suppresses sodium-induced hypertension through increased secretion of urinary kallikrein.
Hypertens. Res. 32(3) , 220-6, (2009) It is suggested that an ATP-sensitive potassium channel blocker suppresses sodium-induced hypertension through increased secretion of urinary kallikrein. We reported that glibenclamide, an ATP-sensiti... |
| 4-Morpholinecarboximidamide, N,N'-dicyclohexyl- |
| N,N'-Dicyclohexyl-4-morpholine carboxamidine |
| 4-(N,N'-Dicyclohexylcarbamimidoyl)morpholine |
| N,N'-Dicyclohexyl-4-morpholinecarboxamidine |
| 4-(N,N'-Dicyclohexylamidino)morpholine |
| N,N-Dicyclohexyl-4-Morpholinecarboxamidine |
| MFCD00063252 |
| N,N'-Dicyclohexyl-4-morpholinecarboximidamide |
| N,N'-Dicyclohexylmorpholine-4-carboximidamide |
| EINECS 225-622-1 |
| N,N′-Dicyclohexyl-4-morpholinecarboxamidine |